x
- Home
- About Diabetes
- Services
- Diabetes Mellitus Modeling Solutions
- R&D Services for Diabetes Mellitus and Diabetic Complications
- By Drug Development Process
- About Us
- Careers
- Contact Us
Cat. No.: DMM-001134
| Status | Age | Sex |
|---|---|---|
|
|
|
| Product Overview | |
|---|---|
| Model Description | The 3.8 kb region of the -4.6 kb to -0.8 kb upstream of the transcription start site was knocked out to obtain a H19 lncRNA gene mutant mouse strain. |
| Strain Name | C57BL/6J-H19em1 |
| Background Strain | C57BL/6J |
| SPF | Yes |
| Research Application | H19 gene function. |
| Target Information | |
|---|---|
| Target Name | H19 |
| Synonyms | AI747191, EyeLinc6 |
| Gene ID | 14955 |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.
